Peptides are inherently more complex than small molecules, which leads to a broader spectrum of product-related impurities arising during synthesis, purification, formulation, or storage
STEP Trials (Semaglutide Treatment Effect in People with Obesity): STEP trials evaluated semaglutide for weight management in individuals with obesity
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist: A phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
These findings suggest that MB may offer neuroprotection by maintaining ATP production and enhancing blood flow in at-risk brain tissue, making it a promising candidate for clinical stroke trials due to its established safety profile
Under low oxygen conditions, HIF-1 acts as a key modulator of mitochondrial metabolism, actively repressing oxidative phosphorylation (OXPHOS) to reduce cellular oxygen consumption and mitochondrial-generated reactive oxygen species (ROS), which can be toxic at high levels (78)